Skip to content

Drug delivery firm Cure Pharma boosts cannabinoid IP

Drug delivery firm Cure Pharma boosts cannabinoid IP 17-Apr-2018 By Flora Southey Cure Pharmaceuticals has received US patents for its cannabinoid molecule extraction and fractioning process. More

Shire sells cancer biz for $2.4bn

17-Apr-2018 By Flora Southey Shire has sold its oncology business to French firm Servier S.A.S as it looks to better align its long-term strategy. More

New Study Reveals Two Genes Associated with High Risk for ALS

Genetic mutations in two previously unrecognized genes, the microtubule-associated protein tau (MAPT) and BNIP1 genes, are associated with elevated risk for amyotrophic lateral sclerosis (ALS). The study with that finding “Selective genetic overlap between amyotrophic lateral sclerosis and diseases of the frontotemporal dementia spectrum,” was published in the journal JAMA Neurology. As seen in other neurodegenerative diseases, abnormal accumulation of…

Newly-discovered human organ may help explain how cancer spreads

… Cancer transport But as well as protecting organs, the network may also aid the spread of cancer. When Theise’s team looked at samples taken from people with invasive cancers, they found evidence that cancer cells that had worked their way out of their original tissues could find their way into these channels, which took…

Servier and Treventis begin strategic research partnership in neurodegenerative diseases

March 8, 2018 – Servier, Pfizer Inc. (NYSE: PFE) and Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS), today announced that results from the two phase 1 trials with UCART19, the allogeneic anti-CD19 CAR T-cell product being developed by Servier and Pfizer, will be presented during the European society for Blood and Marrow Transplantation (EBMT) Annual Meeting…

Democrats sink House vote on Trump-backed drug bill

House Republicans failed Tuesday evening to pass a “right-to-try” bill that would give terminally ill patients access to experimental drugs without FDA authorization after failing to muster enough votes to approve it through an expedited process. The 259-140 vote fell short of the necessary two-thirds support from the House chamber. The failed vote is a…

BCLI: PHASE 3 TRIAL IN ALS ENROLLING PATIENTS

BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) has enrolled the first patients in the Phase 3 clinical trial of NurOwn® (NCT03280056) for the treatment of amyotrophic lateral sclerosis (ALS). The trial is taking place at six leading U.S. Medical centers. It is a randomized, double blind, placebo controlled, multi-dose trial that is expected to enroll approximately 200…

Japan’s New Drug: One Pill May Stop The Flu in Just One Day

One day, you may be able to stop flu viruses in your body in just one day with just one pill. Based on an announcement yesterday, that day may be someday very soon in May in Japan. On Friday, Japanese pharmaceutical company Shionogi announced that the flu medication that they have developed, Xofluza, otherwise known…

Digital Drug Development Services Provider Transparency Life Sciences Raises $5.0 Million in Series A Financing

New York, NY — February 15, 2018 — Transparency Life Sciences (TLS), a pioneer in digital drug development clinical services, today announced completion of a $5.0 million Series A financing led by venture investor New Ventures III. Existing private investors also participated. TLS will use the new financing to expand the company’s technology platform and…

New Israeli bandage stops uncontrollable bleeding

Was Once Thought to Be ‘Uncontrollable’ Bleeding The new technology is hailed by its inventors as a life-saving bandage that can succeed where conventional treatment procedures might fail to stop a deadly hemorrhage. More at: https://www.haaretz.com/israel-news/new-israeli-bandage-can-stop-uncontrollable-bleeding-1.5402251